NCT01679613View on ClinicalTrials.gov

Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

Nintedanib

low or medium dose depending on pilot part

DRUG

Nintedanib

low dose oral administration

DRUG

Ketoconazole

oral administration

DRUG

Nintedanib

low dose oral administration

DRUG

Nintedanib

low or medium dose depending on pilot part

DRUG

Ketoconazole

oral administration

Trial Locations (1)

Unknown

1199.161.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01679613 - Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter